Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)

Overview

A study to asses the safety and efficacy of MK0429 in postmenopausal women with osteoporosis.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double
  • Study Primary Completion Date: October 2002

Interventions

  • Drug: MK0429

Participating in This Clinical Trial

Inclusion Criteria

  • Person is a women with osteoporosis who is unwilling or unable to take other treatments for osteoporosis Exclusion Criteria:

  • Person has had a previous fracture – Person has rheumatoid arthritis. Person has has certain types of cancer – Person has donated blood or has been in another investigational study within the last 4 weeks

Gender Eligibility: Female

Minimum Age: 50 Years

Maximum Age: 75 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Merck Sharp & Dohme LLC
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Medical Monitor, Study Director, Merck Sharp & Dohme LLC

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.